Johne's Disease (cattle, sheep, goats)

Johne's disease, scientifically known as paratuberculosis, is a chronic, progressive, and ultimately fatal gastrointestinal infection that affects ruminant animals including cattle, sheep, goats, deer, and other species with multi-chambered stomachs. The disease is caused by Mycobacterium avium subspecies paratuberculosis (MAP), a hardy bacterium that can survive in the environment for extended periods, making eradication extremely challenging once a herd becomes infected. This insidious condition represents one of the most economically devastating diseases affecting the global dairy and beef industries, with losses attributed to reduced milk production, premature culling, decreased slaughter value, and restricted trade opportunities for infected herds.

The prevalence of Johne's disease varies considerably across different regions and production systems, but studies consistently demonstrate that the infection is widespread in cattle populations throughout North America, Europe, Australia, and other major livestock-producing regions. Research indicates that between 20 to 40 percent of dairy herds in the United States harbor infected animals, though infection rates within individual herds can range from minimal to nearly complete herd involvement. Sheep and goat populations similarly experience significant infection rates, particularly in operations with intensive management practices or those that have unknowingly introduced infected breeding stock into their flocks.

The economic and welfare impact of Johne's disease extends far beyond the obvious costs of clinical cases and animal deaths. Subclinically infected animals, those harboring the bacteria without showing obvious symptoms, experience reduced feed efficiency, decreased milk production, and compromised reproductive performance long before clinical signs become apparent. These hidden losses accumulate substantially over time, and studies estimate that subclinical Johne's disease may reduce milk production by 4 to 16 percent in infected dairy cows compared to their uninfected herdmates. The welfare implications are equally concerning, as affected animals experience progressive weight loss, chronic diarrhea, and eventual debilitation despite maintaining their appetite in most cases.

Understanding Johne's disease is critical for livestock producers because no effective treatment or cure currently exists, making prevention and control the only viable management strategies. Early detection through regular testing programs enables producers to identify infected animals before they shed large quantities of bacteria into the environment and expose susceptible herdmates. The extended incubation period, typically ranging from two to ten years between initial infection and clinical disease manifestation, means that many animals become infected as calves or kids but don't display recognizable symptoms until they reach productive adulthood, complicating control efforts and emphasizing the importance of comprehensive, long-term management programs.

The primary cause of Johne's disease is infection with Mycobacterium avium subspecies paratuberculosis (MAP), a slow-growing, acid-fast bacterium closely related to the organisms that cause tuberculosis in humans and animals. This pathogen possesses a remarkably thick, waxy cell wall that enables it to survive in hostile environments including soil, water, and manure for periods exceeding one year under favorable conditions. The bacterium is transmitted primarily through the fecal-oral route, with young animals becoming infected by ingesting colostrum, milk, or environmental materials contaminated with feces from infected adults. In utero transmission can also occur when fetuses become infected through the bloodstream of heavily infected dams, and this vertical transmission pathway may account for a significant percentage of new infections in some herds.

While Johne's disease is not considered hereditary in the traditional sense, genetic factors play an important role in determining individual animal susceptibility to infection and disease progression. Research has identified specific genetic markers and breeding lines that demonstrate increased resistance or susceptibility to MAP infection, and ongoing genetic studies aim to develop selection tools that will allow producers to breed for enhanced disease resistance. Some cattle breeds appear more susceptible than others, though management factors and exposure levels often confound breed comparisons. The heritability of resistance to Johne's disease is estimated to be moderate, suggesting that selective breeding programs could eventually contribute to reduced disease prevalence within herds and populations.

Environmental and management factors significantly influence the transmission dynamics and prevalence of Johne's disease within livestock operations. Intensive housing systems where animals are concentrated in confined spaces increase the likelihood of fecal contamination of feed and water sources, thereby amplifying exposure risk for susceptible young stock. Calving or kidding environments are particularly critical, as newborns are most susceptible to infection during their first hours and days of life when their intestinal barriers are still developing. Farms that practice communal housing of young animals, share equipment between infected and clean groups, or fail to implement adequate manure management protocols create conditions that favor disease transmission and persistence.

Several risk factors predispose individual animals and herds to Johne's disease infection and clinical manifestation. Age at exposure is paramount, with animals infected in the first weeks of life most likely to develop clinical disease later in life, while exposure in adult animals rarely results in progressive infection. Stress factors including nutritional deficiencies, concurrent diseases, parasitism, and the physiological demands of lactation or late pregnancy can accelerate disease progression in subclinically infected animals. Herd size correlates with infection probability, as larger operations typically experience more animal movements, purchase more replacement stock, and face greater challenges in maintaining biosecurity compared to smaller, closed herds.

The pathophysiology of Johne's disease involves a complex interaction between the invading bacteria and the host's immune system that results in chronic, granulomatous inflammation of the intestinal wall. Following ingestion, MAP organisms are taken up by specialized immune cells called macrophages in the intestinal lining, but instead of being destroyed, the bacteria survive and multiply within these cells. The immune system mounts an inflammatory response that thickens the intestinal wall over time, progressively impairing the animal's ability to absorb nutrients and fluids from digested feed. This malabsorption syndrome ultimately produces the characteristic clinical signs of weight loss and diarrhea, though the extended period between infection and clinical disease reflects the slow, relentless nature of the bacterial multiplication and tissue damage.

The early warning signs of Johne's disease are notoriously subtle and easily overlooked, which contributes to the widespread distribution of the infection before producers recognize its presence in their herds. Initially, affected animals may display slightly reduced body condition compared to their contemporaries, requiring careful observation and body condition scoring to detect. A gradual decline in milk production often precedes other clinical signs in dairy animals, though this reduction may be attributed to other factors such as nutrition, stage of lactation, or subclinical mastitis. Alert producers may notice that certain animals consistently fail to maintain condition despite adequate nutrition, appearing slightly ribby or showing prominent hip bones even when receiving the same ration as thriving herdmates.

The common symptoms of Johne's disease share similarities across cattle, sheep, and goats, though some species-specific variations exist. In cattle, the hallmark clinical sign is persistent, watery diarrhea that does not respond to standard treatments for parasites or infectious causes. This diarrhea typically appears intermittently at first, often coinciding with periods of stress such as calving or peak lactation, before becoming progressively more constant and severe. Sheep and goats with clinical Johne's disease may not develop the profuse diarrhea seen in cattle, instead presenting primarily with progressive weight loss, a condition sometimes called thin ewe syndrome. The submandibular edema, commonly known as bottle jaw, occurs in some affected animals as protein loss from the damaged intestines reduces blood protein levels.

Behavioral changes often accompany the physical manifestations of Johne's disease and may provide early clues to observant caretakers. Despite their declining condition, most animals with Johne's disease maintain a good appetite, which distinguishes this condition from many other wasting diseases. Affected animals may become separated from the main group, not through active isolation but through inability to keep pace during grazing or movements to and from milking parlors. The persistence of appetite alongside obvious weight loss creates a paradoxical clinical picture that should raise suspicion for Johne's disease in any ruminant species. Some animals become less competitive at feed bunks, allowing more aggressive herdmates to displace them despite their evident hunger.

The physical signs of clinical Johne's disease become increasingly apparent as the condition progresses beyond its early stages. The characteristic diarrhea in cattle is described as homogeneous and pipe-stream in nature, often lacking the mucus, blood, or undigested material that might indicate other intestinal disorders. Hair coat quality deteriorates in affected animals, becoming rough, dull, and sometimes developing a characteristic wavelike appearance along the topline. Muscle wasting becomes prominent over the hindquarters and along the spine, with severely affected animals developing a skeletal appearance despite continued feed intake. The skin loses its normal elasticity due to chronic dehydration, and affected cattle often develop loose, wrinkled skin over the neck and shoulders sometimes described as having a aged appearance.

Symptom progression in Johne's disease follows a predictable but variable timeline that typically spans months once clinical signs first appear. Early clinical cases may experience periods of apparent improvement, particularly when environmental conditions are favorable and stress levels are reduced, only to relapse when conditions change. As the disease advances, diarrhea becomes increasingly intractable, weight loss accelerates despite nutritional intervention, and affected animals develop weakness and reluctance to move. The protein-losing enteropathy worsens, potentially leading to dependent edema under the jaw, along the brisket, and occasionally in the limbs. Terminal stages are characterized by extreme emaciation, profound weakness, recumbency, and death, typically occurring within six months to two years after the first appearance of clinical signs.

Several emergency symptoms and situations require immediate veterinary intervention when Johne's disease is suspected or confirmed in an animal. Sudden deterioration in a known positive animal may indicate complications such as concurrent infection or metabolic derangement requiring supportive care. Pregnant animals in advanced stages of clinical Johne's disease require careful monitoring as they approach calving or kidding, as they may lack the physical reserves to survive parturition without assistance. Any animal that becomes recumbent or unable to rise needs immediate attention to prevent suffering and to make timely decisions regarding humane euthanasia. Producers should establish clear protocols with their veterinarians for managing terminal cases to ensure animal welfare is prioritized throughout the disease course.

Clinical examination for Johne's disease begins with a thorough physical assessment and careful review of the animal's history and production records. Veterinarians evaluate body condition, hydration status, fecal consistency, and overall appearance while gathering information about the duration of symptoms, response to previous treatments, and whether other animals in the herd have shown similar signs. The characteristic combination of persistent diarrhea and progressive weight loss despite maintained appetite raises strong clinical suspicion for Johne's disease in cattle, while weight loss alone may suggest the condition in sheep and goats. Physical examination may reveal thickened intestinal loops palpable through the right abdominal wall in cattle, though this finding is not consistently present. Rectal examination can sometimes detect the corrugated texture of severely affected intestinal segments in advanced cases.

Multiple diagnostic tests are available for detecting Johne's disease, each with specific advantages, limitations, and appropriate applications. Enzyme-linked immunosorbent assay (ELISA) blood tests detect antibodies against MAP and are widely used for herd screening due to their relatively low cost and ease of sample collection. However, ELISA tests have limited sensitivity in early infection because animals may not produce detectable antibodies until disease has progressed substantially, meaning false-negative results are common in subclinically infected animals. Fecal culture and fecal polymerase chain reaction (PCR) tests directly detect the organism in manure samples, offering higher sensitivity for identifying shedding animals, though fecal shedding can be intermittent in early cases. Necropsy examination with tissue culture and histopathology provides definitive diagnosis in deceased animals and reveals the characteristic thickened, corrugated intestinal mucosa with granulomatous inflammation and acid-fast bacteria.

Differential diagnosis for Johne's disease requires consideration of numerous other conditions that produce similar clinical presentations in ruminants. Gastrointestinal parasitism, particularly heavy burdens of Ostertagia or Haemonchus species, can cause diarrhea, weight loss, and hypoproteinemia resembling Johne's disease. Chronic salmonellosis, bovine viral diarrhea, copper deficiency, protein-energy malnutrition, dental problems, and various neoplastic conditions must all be considered and ruled out through appropriate diagnostic testing. Liver fluke infestation produces weight loss and submandibular edema similar to Johne's disease and shares geographic risk factors with paratuberculosis in some regions. Veterinarians often recommend testing for multiple conditions simultaneously to avoid delayed diagnosis when Johne's disease mimics other treatable conditions.

Herd-level diagnostics play an essential role in Johne's disease control programs because individual animal testing cannot capture the full picture of infection status within a population. Environmental sampling, in which manure from housing areas, lagoons, or collection points is tested for MAP by PCR, can indicate whether infection is present in a herd without testing every animal. Bulk tank milk testing provides a convenient screening option for dairy operations, detecting antibodies or organisms shed by infected cows contributing to the pooled milk supply. Strategic individual testing programs may target specific groups such as mature cows, animals with reduced production, or those being considered for breeding stock sales. Veterinarians work with producers to design testing protocols appropriate for their herd size, production system, management goals, and available resources, recognizing that no single test or testing strategy is perfectly suited to all situations.

Immediate treatment considerations for animals with clinical Johne's disease focus on supportive care and welfare assessment rather than cure, as no treatment effectively eliminates MAP infection or reverses intestinal damage. Veterinarians and producers must make honest evaluations about the animal's current quality of life and likely trajectory, recognizing that clinical Johne's disease is invariably progressive and fatal. Initial supportive measures may include fluid therapy to address dehydration, nutritional support through highly digestible feeds, and treatment of concurrent conditions that may be exacerbating the animal's decline. Anti-inflammatory medications can provide temporary comfort for some animals, though their benefit is limited and they do not address the underlying disease process. The decision to initiate treatment versus proceeding directly to humane euthanasia depends on the animal's current condition, the producer's goals, and practical considerations such as food safety withdrawal periods.

Medical management options for Johne's disease are extremely limited, and producers must understand that treatment does not cure infection or prevent shedding of organisms to other animals. Antimicrobial therapy with drugs active against mycobacteria, such as isoniazid or clofazimine, has been attempted experimentally but does not produce reliable clinical improvement and is not approved for use in food-producing animals. These treatments would require extended withdrawal periods that effectively eliminate the treated animal from the food supply. Symptom management through antidiarrheal medications may temporarily reduce fluid loss but does not address malabsorption or weight loss, and treated animals continue to shed bacteria and potentially infect herdmates. No vaccines currently licensed in most countries provide reliable protection against Johne's disease, though experimental vaccines and vaccination programs exist in some regions with specific regulatory approval.

Surgical intervention has no role in the management of Johne's disease given the diffuse nature of intestinal involvement and the systemic distribution of the infection. Unlike conditions where localized lesions might be addressed through resection or bypass procedures, the granulomatous inflammation in Johne's disease affects extensive segments of intestinal tissue and cannot be surgically corrected. The focus of veterinary intervention therefore remains on diagnostic confirmation, supportive care decisions, and guidance regarding herd management rather than individual animal treatment aimed at cure or long-term survival.

Supportive care for animals maintained during clinical Johne's disease emphasizes nutrition, comfort, and minimizing stress while preventing exposure of susceptible herdmates. High-quality, highly digestible feeds should be offered to maximize nutrient absorption from compromised intestines. Clean, dry, well-bedded housing reduces energy expenditure and improves animal comfort. Separation from the main herd prevents fecal contamination of shared environments and reduces competitive pressure at feed and water sources. Frequent monitoring allows early recognition of deterioration so that humane endpoints can be implemented before suffering becomes severe. Some producers elect to maintain valuable animals for limited periods to obtain additional offspring or allow pregnancy completion, but these decisions must be weighed against welfare considerations and biosecurity risks.

Herd treatment protocols for Johne's disease focus on management-based control rather than therapeutic intervention because no herd treatments eliminate infection. Vaccination programs where approved can reduce clinical disease incidence and fecal shedding levels, though they do not prevent infection and may interfere with diagnostic testing. Test-and-cull programs systematically identify and remove infected animals to reduce environmental contamination and transmission pressure over time. Hygiene-focused protocols emphasize separation of susceptible young stock from potential sources of contamination including adult manure, contaminated colostrum, and infected cohorts. These herd-level interventions require sustained commitment over many years because the long incubation period means that animals infected before program implementation will continue to emerge as clinical cases for years afterward.

Treatment decisions for individual animals with Johne's disease involve complex considerations balancing animal welfare, economic factors, biosecurity, and producer values. Humane euthanasia is often the most appropriate recommendation for animals with clinical disease, as it prevents continued suffering, eliminates ongoing environmental contamination, and allows the animal to enter the food chain before becoming condemned due to emaciation. Animals salvaged for slaughter must meet food safety requirements including freedom from drug residues and minimum body condition standards. Valuable animals such as superior genetics or rare breeds may warrant extended management to allow embryo collection or obtain offspring, but these situations require careful biosecurity measures and honest welfare assessment. Veterinarians should provide clear, compassionate guidance to help producers navigate these difficult decisions while prioritizing animal welfare and herd health goals.

The recovery timeline for animals with clinical Johne's disease must be understood within the context that true recovery, meaning elimination of infection and restoration of normal intestinal function, does not occur with currently available interventions. Animals that appear to improve temporarily during favorable conditions or following supportive care remain infected and will inevitably progress to terminal disease. These apparent improvements typically reflect reduction in stress factors, better environmental conditions, or earlier stage of disease rather than actual healing of intestinal lesions. Producers should not interpret temporary stabilization as evidence of recovery or reason to retain infected animals in the breeding herd. The realistic timeline for clinical cases extends from initial symptom recognition through progressive decline over weeks to months, culminating in death or euthanasia in virtually all cases.

Post-treatment care and monitoring for animals managed through clinical Johne's disease requires intensive observation and honest, ongoing welfare assessment. Daily evaluation of appetite, fecal consistency, hydration status, and mobility helps track disease progression and informs decisions about continued management versus euthanasia. Body condition scoring at regular intervals documents the trajectory of weight change and provides objective data for decision-making. Animals maintained during clinical disease should be housed separately from the main herd to prevent environmental contamination and allow focused attention to their needs. Establishing clear criteria for humane endpoints before beginning supportive management helps ensure that animals do not experience unnecessary suffering as their condition deteriorates.

Prognosis factors for Johne's disease are uniformly unfavorable once clinical signs develop, though the rate of progression varies among individual animals. Animals that develop clinical disease at younger ages may experience more rapid progression compared to those that remain subclinical until later in life. Concurrent stressors including other diseases, parasitism, nutritional deficiencies, or pregnancy and lactation demands can accelerate decline. The severity of intestinal lesions at the time clinical signs first appear influences how quickly malabsorption and weight loss progress. Animals with access to high-quality nutrition, low stress environments, and excellent supportive care may survive longer than those facing challenging conditions, but extended survival simply prolongs the eventual inevitable outcome rather than altering it.

Return to production considerations are largely irrelevant for animals with clinical Johne's disease because affected animals never regain productive capacity and pose ongoing contamination risks to the herd. Subclinically infected animals may continue productive lives for years before developing clinical disease, but these animals should be identified through testing and managed according to herd control program protocols rather than being considered recovered or safe. Animals that test positive but remain clinically normal may be managed through strategic culling, with timing influenced by factors such as current production level, replacement availability, and reproductive status. The goal of Johne's disease programs is prevention of new infections and gradual reduction in prevalence rather than returning affected individuals to normal production status.

Vaccination protocols for Johne's disease exist in some jurisdictions but remain controversial and are not universally available or recommended. Where approved, killed whole-cell or modified live vaccines can reduce clinical disease incidence and decrease the level of environmental contamination from fecal shedding. However, vaccination does not prevent infection, and vaccinated animals can still become infected and transmit bacteria to susceptible herdmates. Vaccination interferes with tuberculosis testing, creating regulatory complications for herds subject to TB surveillance programs. Some regional control programs incorporate vaccination as one component of comprehensive control strategies, while others prohibit or discourage vaccination due to diagnostic interference concerns. Producers should consult with their veterinarians and regulatory authorities to understand local policies before considering vaccination programs.

Biosecurity measures form the cornerstone of Johne's disease prevention and are essential for protecting clean herds and reducing transmission within infected herds. Closed herd management, where no outside animals are introduced, provides the most effective protection against bringing infection onto a farm. When purchasing animals, producers should require testing of both the individual animal and the source herd, request documentation of the seller's Johne's disease status and testing history, and quarantine new arrivals for appropriate testing and observation. Separating young stock from adult animals and their manure reduces exposure during the most susceptible life stage. Calving and kidding areas should be clean, well-bedded, and separate from areas where infected or high-risk adults are housed. Colostrum and milk management programs that avoid feeding pooled milk or colostrum from untested or positive dams further reduce transmission risk.

Nutritional prevention of Johne's disease focuses on maintaining optimal immune function and reducing stress rather than directly preventing infection. Well-nourished animals with balanced mineral and vitamin intake mount more effective immune responses that may delay disease progression in infected individuals. Trace mineral supplementation, particularly ensuring adequate copper, zinc, and selenium status, supports immune system function. Avoiding nutritional stress during critical periods such as transition, early lactation, and late gestation helps maintain resistance to disease progression. While nutritional management cannot prevent infection or eliminate the organism, optimizing nutrition represents good husbandry that benefits overall herd health and may extend the productive life of subclinically infected animals.

Management practices that reduce Johne's disease transmission emphasize limiting young animal exposure to adult feces during the vulnerable neonatal period. Immediate removal of newborn calves or kids from dams, before nursing in contaminated environments, eliminates exposure to feces adhering to udders, bedding, and birth fluids. Feeding heat-treated colostrum and pasteurized milk or high-quality milk replacer prevents transmission through contaminated milk. Housing young stock in clean, dedicated facilities separate from adult animals and using dedicated equipment for young animal care prevents cross-contamination. Manure management systems that minimize contact between young animals and adult waste, including proper composting, storage, and application practices, reduce environmental contamination.

Quarantine and testing protocols provide structured approaches for identifying infected animals and managing their disposition to reduce herd-level infection pressure. New animal quarantine periods should extend long enough to allow appropriate testing and observation, recognizing that single negative tests do not reliably exclude infection due to intermittent shedding and delayed antibody development. Whole-herd testing programs using serologic, fecal, or combined approaches identify the majority of shedding animals, though sensitivity limitations mean some infected animals will be missed on any single test. Risk-based testing strategies target animals most likely to be shedding, such as older cows, lower producers, or those with suggestive clinical signs. Progressive programs implement test-and-cull strategies that remove positive animals over time, gradually reducing environmental contamination and transmission pressure while avoiding the economic shock of immediate wholesale culling.

Daily management and monitoring for Johne's disease control requires systematic attention to individual animals and environmental conditions that influence disease transmission. Observation of fecal consistency during routine activities such as milking or feeding helps identify animals developing clinical signs. Body condition scoring programs track individual animal changes over time, flagging those failing to maintain condition for further evaluation and testing. Record keeping systems should document test results, clinical observations, dam identification, and dates of birth to enable tracing of infection patterns and evaluation of control program effectiveness. Daily monitoring of young stock ensures early detection of any gastrointestinal abnormalities and confirms that management protocols separating them from potential contamination sources are being followed consistently.

Housing and environmental management significantly influence Johne's disease transmission dynamics and control program success. Maternity facilities should be clean, well-bedded, and designed to minimize newborn contact with adult manure, with protocols for thorough cleaning and disinfection between uses. Calf housing should be physically separated from adult cattle areas, ideally in locations where runoff, equipment sharing, and air movement do not transfer contamination. Manure handling systems should minimize accumulation in areas where young or susceptible animals are housed and prevent contamination of feed storage and feeding areas. Pasture management considerations include avoiding grazing young stock on pastures recently contaminated by adult cattle, particularly in moist, shaded areas where MAP organisms survive longest in the environment.

Herd health programs incorporating Johne's disease control integrate testing, management interventions, and documentation into systematic approaches for reducing prevalence over time. Formal programs such as the Voluntary Bovine Johne's Disease Control Program provide frameworks for risk assessment, management practice implementation, and progressive testing strategies. Program participation may offer marketing advantages through recognized low-risk status and improved access to sales requiring health documentation. Veterinarians serve as essential partners in designing and implementing herd-specific control programs, interpreting test results, making culling recommendations, and evaluating program effectiveness. Sustained commitment over many years is required because the long incubation period means infected animals may continue appearing for a decade or more after program initiation.

Record keeping and monitoring systems enable evaluation of Johne's disease control program effectiveness and support informed management decisions. Individual animal records should include all test results with test types and dates, clinical observations, dam identification, purchase source information, and dates of removal with reasons. Herd-level metrics tracking the percentage of animals testing positive, clinical case incidence, and removal rates over time demonstrate whether control efforts are reducing prevalence. Graphing these trends helps visualize progress and maintains motivation during the extended timeframes required for meaningful improvement. Integration of Johne's disease records with general herd management software facilitates analysis and ensures information is readily accessible when needed for management decisions, sales documentation, or regulatory inquiries.

Economic considerations for Johne's disease management include both the direct costs of testing and control program implementation and the ongoing losses attributed to infection within the herd. Testing costs vary by method, with ELISA serology generally least expensive, fecal PCR intermediate, and fecal culture most costly but most sensitive. Culling costs include the value of removed animals offset by salvage value, plus the cost of raising or purchasing replacements. These expenditures must be weighed against the ongoing economic impact of infection, including reduced milk production in subclinically infected animals, premature removal of clinical cases, restricted marketability of breeding stock, and potential liability concerns. Economic modeling specific to individual herd circumstances helps producers evaluate whether intensive control programs, moderate testing and management approaches, or maintenance strategies best fit their operations and goals.

All ruminant species are susceptible to Johne's disease, though certain breeds and populations demonstrate differences in infection rates and disease manifestation. Among cattle, dairy breeds generally show higher prevalence than beef breeds, though this difference likely reflects management and exposure patterns rather than inherent susceptibility differences. Holstein cattle, as the predominant dairy breed worldwide, constitute the majority of reported cases simply due to their population size and the intensive monitoring common in dairy operations. Jersey cattle have been suggested in some studies to show higher susceptibility, though research results are inconsistent. Beef cattle raised extensively on pasture typically experience lower transmission pressure than intensively housed dairy cattle, resulting in lower apparent prevalence rather than true breed resistance.

Production type considerations significantly influence Johne's disease risk independent of genetic breed susceptibility. Dairy operations face higher risk due to intensive housing, extended productive life spans allowing disease progression, pooled colostrum and milk practices, and purchase of replacement animals from multiple sources. High-producing dairy cattle may show accelerated clinical progression due to metabolic stress associated with peak lactation. Beef cattle in cow-calf operations experience lower transmission pressure when managed extensively, though feedlot cattle face increased risk when concentrated in close quarters. Sheep and goat dairies encounter similar risk factors as cattle dairies, while extensively managed meat-producing flocks maintain lower prevalence. Commercial poultry are not susceptible to Johne's disease, but backyard poultry operations housing mixed species should recognize that ruminants on the same premises may be at risk.

Genetic selection and testing for Johne's disease resistance represent emerging tools that may eventually contribute to control efforts alongside traditional management-based approaches. Research has identified genetic markers associated with resistance or susceptibility to MAP infection, and genomic testing can estimate individual animal breeding values for disease resistance. Bulls and breeding animals can be selected to produce offspring with improved resistance, gradually shifting herd genetics toward reduced susceptibility over generations. Genetic selection should complement, not replace, management-based control programs because environmental contamination and exposure pressure remain primary determinants of transmission. Producers interested in incorporating genetic selection into their Johne's disease control strategies should consult with breed associations, genetics companies, and veterinarians familiar with current research and available tools.

Several conditions commonly co-occur with Johne's disease or develop as consequences of the primary infection and its effects on animal health. Secondary bacterial infections may establish as the compromised intestinal barrier allows opportunistic organisms to invade, and affected animals may develop pneumonia, mastitis, or other infections due to generalized immune suppression. Hypoproteinemia resulting from intestinal protein loss leads to dependent edema, reduced immune function, and impaired wound healing. Concurrent parasitism often exacerbates clinical signs, as the damaged intestinal tract cannot tolerate parasite burdens that healthy animals might manage without clinical impact. Trace mineral and vitamin deficiencies may develop due to malabsorption, compounding the animal's decline even when dietary provision is adequate.

Multiple conditions produce clinical presentations similar to Johne's disease, requiring careful diagnostic differentiation to ensure appropriate management. Gastrointestinal parasitism, particularly ostertagiosis in cattle and haemonchosis in sheep and goats, causes diarrhea, weight loss, and hypoproteinemia closely resembling Johne's disease, though parasitism typically responds to appropriate anthelmintic treatment. Chronic salmonellosis produces persistent diarrhea and systemic illness that may be confused with Johne's disease, and the two conditions can occur simultaneously. Copper deficiency causes weight loss, rough hair coat, and diarrhea in cattle, particularly in regions with molybdenum-rich soils that interfere with copper availability. Bovine viral diarrhea virus infection can produce chronic wasting with intestinal involvement resembling Johne's disease. Hardware disease causing chronic peritonitis and protein-losing enteropathy from intestinal lymphoma represent additional differential diagnoses in cattle.

Complications and sequelae of Johne's disease primarily result from progressive malnutrition, protein loss, and debilitation rather than from spread of infection to other body systems. Recumbency in terminal cases leads to pressure sores, muscle damage, and inability to access feed and water without assistance. Pregnancy complications may occur in affected dams due to inadequate nutritional reserves for fetal development and parturition. Calves and kids born to clinically affected dams often experience poor colostrum quality and reduced passive transfer of immunity. The immunosuppression associated with advanced Johne's disease predisposes to various opportunistic infections. Following death, carcass disposal requires consideration of the potential for environmental contamination, as MAP organisms can persist in buried or composted remains and potentially contaminate soil and water.